Linking immunometabolic and epigenomic remodeling in monocytes and macrophages during HIV infection
Despite the effectiveness of antiretroviral therapy (ART), chronic immune activation and inflammation persist in people living with HIV (PLWH), with monocytes and macrophages playing a key role in viral persistence and immune dysregulation. Recent research has identified metabolic remodeling in these cells, characterized by enhanced glucose utilization, mitochondrial and redox dysfunction, and impaired cholesterol homeostasis. These changes, alongside alterations in DNA methylation, chromatin accessibility, and transcription, modulate inflammatory and antimicrobial functions, often persisting beyond the initial stimulus. In this minireview, we summarize the current evidence on the metabolic, epigenomic, and transcriptional reprogramming of monocytes and macrophages during HIV infection and ART. We further examine whether metabolic remodeling contributes to persistent myeloid phenotypes through epigenomic mechanisms. Although direct evidence linking these processes remains limited, data from studies involving Nef-containing extracellular vesicles is promising. Further integrated and longitudinal studies are required to establish causality and elucidate the mechanisms connecting metabolic and epigenomic remodeling in HIV.
Authors
- Yusuke Yoshino (ORCID: https://orcid.org/0000-0002-3633-4243)
- Yoshitaka Kimura (ORCID: https://orcid.org/0000-0001-5430-9909)
- Atsushi Fukumoto
Institutions
- Teikyo University (JP)
Publication Details
- Journal
- Frontiers in Cellular and Infection Microbiology
- Published
- 2026-11-17
- DOI
- https://doi.org/10.3389/fcimb.2026.2021952
- Primary Topic
- HIV Research and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Okinaka Memorial Institute for Medical Research
- Research Promotion Foundation
- Shionogi
- Japan Society for the Promotion of Science
- Shionogi Infectious Disease Research Promotion Foundation